510(k) Report

510(k) · Cleared

Cleared

Encore Hip Stems with Ceramic Heads and Uhmwpe Liners

K082398510(k) SpecialCleared Oct 15, 200856-day reviewClass II21 CFR 888.3353

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Encore Medical L.P. · LZO Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented

Cleared on Oct 15, 2008 as substantially equivalent to K955563 (Encore Orthopedics, Inc., 1996) after a 56-day review. Its family tree reaches back 2 generations to 1994.

Decided
Oct 15, 2008
Review
56 days
Class
Class II
Product code
LZO
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K930963 (1994). No later device cites it as a predicate yet.

  1. Root · 2 generations backK930963 SL-Plus & SLR-Plus Stems W/Biolox Ceramic HeadsEncore Orthopedics, Inc. · 1994
  2. 1 generation backK955563 Foundation Forged, Textured & Porous Stems W/Biolox Ceramic HeadsEncore Orthopedics, Inc. · 1996
  3. This deviceK082398 Encore Hip Stems with Ceramic Heads and Uhmwpe LinersEncore Medical L.P. · 2008
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K930963SL-Plus & SLR-Plus Stems W/Biolox Ceramic HeadsEncore Orthopedics, Inc.1994—
−1K955563Foundation Forged, Textured & Porous Stems W/Biolox Ceramic HeadsEncore Orthopedics, Inc.1996—
0 (this device)K082398Encore Hip Stems with Ceramic Heads and Uhmwpe LinersEncore Medical L.P.2008—
FIG. 1 — Lineage of K082398, 1994–2008Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LZO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LZO device

  1. #1 K192827 Quadra-Pscore 19.3 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K955563Foundation Forged, Textured & Porous Stems W/Biolox Ceramic Heads
Summary page 1
…nd activity levels and loads of normal healthy bone, they are a means of restoring mobility and reducing pain for many patients. Predicate Device: Foundation Hip Stem - K955563 Comparable Features to Predicate Device(s): Features comparable to predicate devices include the same indications, materials, st…
Encore Orthopedics, Inc.1996—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 14 years and passes through 2 companies; a new generation was cleared every 12.2 years on median.
  • None of the 2 ancestors has a recall.

How does its category compare?

All LZO devices

LZO Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented: FDA decisions, review times, recalls and adverse event reports over 20 years. 2008, this device’s year, is highlighted.

FDA decisions per year · LZO

14in 2025

2007: 92008: 112009: 72010: 152011: 132012: 142013: 262014: 132015: 122016: 102017: 162018: 182019: 282020: 182021: 122022: 112023: 102024: 112025: 142026 (partial year): 9
2007high 28 (2019) · low 7 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LZO

119in 2025

2007: 87 days median2008: 63 days median2009: 83 days median2010: 78 days median2011: 87 days median2012: 98 days median2013: 100 days median2014: 85 days median2015: 115 days median2016: 177 days median2017: 257 days median2018: 163 days median2019: 109 days median2020: 112 days median2021: 170 days median2022: 279 days median2023: 122 days median2024: 111 days median2025: 119 days median2026 (partial year): 102 days median
2007high 279 (2022) · low 63 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LZO

1in 2025

2007: 22008: 132009: 422011: 102012: 142014: 12015: 12016: 92017: 52018: 22019: 42020: 32022: 42023: 22024: 12025: 1
2007high 42 (2009) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LZO

3,244in 2025

2007: 1382008: 1252009: 1892010: 3942011: 5442012: 9632013: 1,3702014: 1,4772015: 1,3482016: 1,7282017: 2,1652018: 3,1332019: 3,0662020: 1,9632021: 2,1992022: 1,9852023: 2,0662024: 2,5862025: 3,244
2007high 3,244 (2025) · low 125 (2008)2025

MAUDE reports naming product code LZO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20079872138
2008116313125
200978342189
201015780394
2011138710544
2012149814963
20132610001,370
2014138511,477
20151211511,348
20161017791,728
20171625752,165
20181816323,133
20192810943,066
20201811231,963
20211217002,199
20221127941,985
20231012222,066
20241111112,586
20251411913,244
202691020—

What is it indicated for?

Total and partial hip replacement is indicated for patients suffering from disability due to:

* noninflammatory degenerative joint disease including osteoarthritis and avascular necrosis of the natural femoral head;

* rheumatoid arthritis;

* correction of functional deformity;

* femoral fracture

This device may also be indicated in the salvage of previously failed surgical attempts.

The Vitality and Keystone are designed for a cementless application while the Alfa II, R120, and R12OPC are designed for either cemented or cementless applications.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K082398: Encore Hip Stems with Ceramic Heads and Uhmwpe Liners.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K082398

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026